The Latest in Global Clinical Transparency and Disclosure

News | Case Studies | Whitepapers

Transparent Thinking Blog

The following case study is based on real work conducted between TrialAssure, MMS, and a top 10 pharma sponsor to accelerate the development of Clinical Study Reports using TrialAssure LINK AI. Problem A top 10 global pharma company launched a challenge to evaluate AI-augmented medical writing for Draft 1 Clinical Study Reports (CSRs). The AI system was required to operate fully within the sponsor’s secure cloud environment and integrate with its proprietary Large Language Model (LLM) under strict governance requirements. The timeline was compressed. After receiving protocols, SAPs, and an extensive list of TLFs, the team had a narrow window to generate both a Draft 1 CSR and Plain Language Summary (PLS). The challenge demanded an unprecedented level of speed and technical precision, with just three (3) days to set up the technical environment and five (5) days to complete the actual document drafts. Solution Using its AI-assisted authoring platform, LINK AI, TrialAssure was selected as one of just a few providers to participate in this program, partnering with MMS, a data-focused CRO, to rapidly deploy the solution within the sponsor’s cloud environment. The team seamlessly integrated the platform with the sponsor’s approved LLMs, configured a structured, AI-driven workflow, and securely ingested sponsor-provided source documents within an accelerated implementation timeline. Our medical writers accessed the sponsor environment to review outputs, refine prompts in real time, and strengthen complex results sections. The team integrated PLS development into the same workflow and produced English, French, and German versions. Then, our technical team addressed deployment and model integration challenges quickly, combining AI acceleration with experienced human oversight. “The team brought strong technical knowledge and medical writing experience together in a way that felt seamless. We were impressed by how responsive the team was, and the improvements made over a short period gave us confidence in its long-term potential.” Results The team successfully delivered a full Draft 1 CSR and PLSs in three (3) languages within just 24 hours of receiving source documents. Additionally, we were able to: Strengthen and expand the CSR template and prompt library. Provide rapid output improvements within mere days. Prove the successful deployment inside a controlled enterprise environment. Position a clear pathway for future enterprise AI-assisted medical writing initiatives. This challenge demonstrated that AI-augmented medical writing with TrialAssure’s LINK AI can function effectively within the strict infrastructure of any pharmaceutical and biotech organization.

Accelerating AI-Augmented CSR Development for a Top Global Biopharma Sponsor

by Staff Writer | April 2026

Posted in Blog, Case Studies

AI for Medical Writing Certification (AIMWC) Program

AI in Medical Writing Certification Program Launched by TrialAssure to Support Greater Adoption Across Pharma and Biotech

by Staff Writer | March 2026

Posted in Blog, News

TrialAssure to Lead Discussions on CCI and Smart Anonymization at PHUSE US Connect 2026 in Austin

by Staff Writer | February 2026

Posted in Blog, News

How Daiichi Sankyo Accelerated Plain Language Summary Development with TrialAssure LINK AI

by Staff Writer | January 2026

Posted in Blog, Case Studies

More News

Clinical Trial Transparency Research & Guidance

TrialAssure: The Ultimate Guide to Anonymization or Redaction of Documents: Strategies, Workflow, and Mindset | pharma | biotech | medical device | transparency | clinical trials | technology, tools, and AI

The Ultimate Guide to Anonymization or Redaction of Documents: Whitepaper

Download our 7-page whitepaper that outlines strategies, workflow, mindset, and future trends for the anonymization and/or redaction of documents in pharma and biotech.

Download Now

Start Plain Language Summaries Early or Get Left Behind : White Paper

Download Now

The Importance of Embracing Anonymization of Personal Information : White Paper

Download Now

More Research

Get Updates on Webinars and Events

You’ll be the first to know!

The Latest in Global Clinical Transparency and Disclosure

Transparent Thinking Blog

Accelerating AI-Augmented CSR Development for a Top Global Biopharma Sponsor

AI in Medical Writing Certification Program Launched by TrialAssure to Support Greater Adoption Across Pharma and Biotech

TrialAssure to Lead Discussions on CCI and Smart Anonymization at PHUSE US Connect 2026 in Austin

How Daiichi Sankyo Accelerated Plain Language Summary Development with TrialAssure LINK AI

Clinical Trial Transparency Research & Guidance

The Ultimate Guide to Anonymization or Redaction of Documents: Whitepaper

Start Plain Language Summaries Early or Get Left Behind : White Paper

The Importance of Embracing Anonymization of Personal Information : White Paper

Get Updates on Webinars and Events

Looking to streamline your clinical trial disclosure and transparency efforts?

Yes, please send me more information about TrialAssure.